Cargando…
Enhanced gefitinib‐induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia‐mutated kinase inhibition in non‐small‐cell lung cancer cells
The epidermal growth factor receptor (EGFR) tyrosine kinase signaling pathways regulate cellular activities. The EGFR tyrosine kinase inhibitors (EGFR‐TKIs) repress the EGFR pathway constitutively activated by somatic EGFR gene mutations and have drastically improved the prognosis of non‐small‐cell...
Autores principales: | Misumi, Keizo, Sun, Jiying, Kinomura, Aiko, Miyata, Yoshihiro, Okada, Morihito, Tashiro, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832868/ https://www.ncbi.nlm.nih.gov/pubmed/26825989 http://dx.doi.org/10.1111/cas.12899 |
Ejemplares similares
-
Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated
por: Park, Soo-Yeon, et al.
Publicado: (2010) -
Ataxia-Telangiectasia Mutated Kinase: Role in Myocardial Remodeling
por: Thrasher, Patsy, et al.
Publicado: (2016) -
Myoclonus in Ataxia–Telangiectasia
por: Termsarasab, Pichet, et al.
Publicado: (2015) -
Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021) -
Synaptonemal complex protein SYCP3 impairs mitotic recombination by interfering with BRCA2
por: Hosoya, Noriko, et al.
Publicado: (2012)